Coty’s and Shiseido’s respective CoverGirl and BareMinerals, both self-proclaimed creators of the clean beauty movement, deceive consumers with their toxic-free, good-for-the-planet advertising into buying PFAS-laced cosmetic products, plaintiffs allege in recent complaints. Plaintiffs against Coty point to the company’s Sustainability Report as further evidence that its promises and practices don’t line up.
Plaintiffs against Coty, Inc. and Shiseido Americas Corporation allege the defendants’ respective CoverGirl and BareMinerals brands misleadingly represent products as safe for people and the environment, when in actuality they contain harmful per- and polyfluoroalkyl substances (PFAS).
According to a proposed class action filed in New York’s Southern District on 14 December 2021, plaintiffs Daian Onaka, et...
Green Pharmaceuticals’ SnoreStop Nasal Spray, previously marketed as “NasoSpray,” still is available even though agency officials on multiple occasions for a month recommended a recall after an April inspection found “gross microbial contamination” in one lot.
Global beauty giant is working to adapt its approach to the prestige market to meet escalating competition, increased points of sale, and more knowledgeable consumers with new shopping habits, CFO Tracey Travis said at the Barclays Global Consumer Staples Conference.
Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.
Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process.
Week after publishing safety alert about OPMS Black Liquid Kratom “linked to serious adverse health effects, including death,” FDA announced market research “to understand and characterize emergent risk/safety and perceived benefits reportedly linked to kratom and psychedelics.” But it withdrew the study 10 days later.
Semi-annual regulatory agenda of non-binding target dates also sets December goal for an NPRM to recognize N-acetyl-L-cysteine as a lawful dietary ingredient. Like IND exemptions rule, item on NAC included for first time in FDA’s list.
